Ret Proto-Oncogene antibody (AA 1012-1042) (HRP)

Catalog No. ABIN1930196

The Rabbit Polyclonal anti-Ret Proto-Oncogene antibody has been validated for WB, ELISA and IHC. It is suitable to detect Ret Proto-Oncogene in samples from Human.

Quick Overview for Ret Proto-Oncogene antibody (AA 1012-1042) (HRP) (ABIN1930196)

Target: Ret Proto-Oncogene (RET)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Ret Proto-Oncogene antibody is conjugated to HRP

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Product Details anti-Ret Proto-Oncogene Antibody (HRP)

Binding Specificity: AA 1012-1042

Specificity: This RET antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1012-1042 amino acids from the C-terminal region of human RET.

Purification: Affinity purified

Isotype: IgG

Application Details

Application Notes: Approved: ELISA, IHC, WB

Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Preservative: Without preservative

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: 4 °C,-20 °C

Storage Comment: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Expiry Date: 6 months

Target Details for Ret Proto-Oncogene

Target: Ret Proto-Oncogene (RET)

Alternative Name: RET

Background: Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase

Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9

Gene ID: 5979

Pathways: RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation